Kamu erişimi zorunlu olan makaleler - Douglas G AltmanDaha fazla bilgi edinin
GenelCancer Research UKMRCNIHRCIHRNIHBHFGatesSNSFCSOWellcomeINSERMNWOEuropean CommissionGovernment of SpainVersus Arthritis, UKZonMwNHMRCHRBESRCNSFDFGEPSRCDoDVADSTGovernment of ItalyDOEUSDAAHAFWONSERCWellcome Trust/DBT India AllianceBBSRCBreast Cancer Now, UKNational Centre for the Replacement, Refinement and Reduction of Animals in Research, UKDoris Duke Charitable FoundationPCORIDHFUK Research & InnovationTUBITAK
Hiçbir yerde sunulmuyor: 30
Analysing data and undertaking meta‐analyses
JJ Deeks, JPT Higgins, DG Altman, Cochrane Statistical Methods Group
Cochrane handbook for systematic reviews of interventions, 241-284, 2019
Zorunlu olanlar: National Institute for Health Research, UK
Development and validation of a prediction model with missing predictor data: a practical approach
Y Vergouwe, P Royston, KGM Moons, DG Altman
Journal of clinical epidemiology 63 (2), 205-214, 2010
Zorunlu olanlar: Cancer Research UK
Ten steps towards improving prognosis research
H Hemingway, RD Riley, DG Altman
Bmj 339, 2009
Zorunlu olanlar: US National Institutes of Health
Visualizing and assessing discrimination in the logistic regression model
P Royston, DG Altman
Statistics in medicine 29 (24), 2508-2520, 2010
Zorunlu olanlar: Cancer Research UK
The EQUATOR Network and reporting guidelines: Helping to achieve high standards in reporting health research studies
I Simera, D Moher, J Hoey, KF Schulz, DG Altman
Maturitas 63 (1), 4-6, 2009
Zorunlu olanlar: Cancer Research UK
Microvessel density as a prognostic factor in non-small-cell lung carcinoma: a meta-analysis of individual patient data
M Trivella, F Pezzella, U Pastorino, AL Harris, DG Altman
The lancet oncology 8 (6), 488-499, 2007
Zorunlu olanlar: Cancer Research UK
Reviews assessing the quality or the reporting of randomized controlled trials are increasing over time but raised questions about how quality is assessed
A Dechartres, P Charles, S Hopewell, P Ravaud, DG Altman
Journal of clinical epidemiology 64 (2), 136-144, 2011
Zorunlu olanlar: Cancer Research UK
Pragmatic trials can be designed as optimal medical care: principles and methods of care trials
J Raymond, TE Darsaut, DG Altman
Journal of clinical epidemiology 67 (10), 1150-1156, 2014
Zorunlu olanlar: Cancer Research UK
Writing a research article that is “fit for purpose”: EQUATOR Network and reporting guidelines
I Simera, DG Altman
BMJ Evidence-Based Medicine 14 (5), 132-134, 2009
Zorunlu olanlar: Canadian Institutes of Health Research, Cancer Research UK
Standard 5: selection, measurement, and reporting of outcomes in clinical trials in children
IP Sinha, DG Altman, MW Beresford, M Boers, M Clarke, J Craig, ...
Pediatrics 129 (Supplement_3), S146-S152, 2012
Zorunlu olanlar: Cancer Research UK
NY‐ESO‐1 specific antibody and cellular responses in melanoma patients primed with NY‐ESO‐1 protein in ISCOMATRIX and boosted with recombinant NY‐ESO‐1 fowlpox virus
JL Chen, A Dawoodji, A Tarlton, S Gnjatic, A Tajar, I Karydis, J Browning, ...
International Journal of Cancer 136 (6), E590-E601, 2015
Zorunlu olanlar: Cancer Research UK, UK Medical Research Council
Peer reviewers identified spin in manuscripts of nonrandomized studies assessing therapeutic interventions, but their impact on spin in abstract conclusions was limited
C Lazarus, R Haneef, P Ravaud, S Hopewell, DG Altman, I Boutron
Journal of clinical epidemiology 77, 44-51, 2016
Zorunlu olanlar: National Institute for Health Research, UK
The time has come to register diagnostic and prognostic research
DG Altman
Clinical chemistry 60 (4), 580-582, 2014
Zorunlu olanlar: Cancer Research UK
Statistical considerations for the development of prescriptive fetal and newborn growth standards in the INTERGROWTH‐21st Project
DG Altman, EO Ohuma, ...
BJOG: An International Journal of Obstetrics & Gynaecology 120, 71-76, 2013
Zorunlu olanlar: Cancer Research UK, Wellcome Trust
Reporting medical research
I Simera, DG Altman
International journal of clinical practice 67 (8), 710-716, 2013
Zorunlu olanlar: UK Medical Research Council
Citation impact was highly variable for reporting guidelines of health research: a citation analysis
L Caulley, W Cheng, F Catalá-López, J Whelan, M Khoury, J Ferraro, ...
Journal of clinical epidemiology 127, 96-104, 2020
Zorunlu olanlar: Cancer Research UK
Standard 3: data monitoring committees
S Ellenberg, RM Fernandes, H Saloojee, D Bassler, L Askie, ...
Pediatrics 129 (Supplement_3), S132-S137, 2012
Zorunlu olanlar: Cancer Research UK
Systematic review: Bias in imaging studies-the effect of manipulating clinical context, recall bias and reporting intensity
D Boone, S Halligan, S Mallett, SA Taylor, DG Altman
European radiology 22, 495-505, 2012
Zorunlu olanlar: US National Institutes of Health
Reporting clinical research: guidance to encourage accurate and transparent research reporting
I Simera, S Kirtley, DG Altman
Maturitas 72 (1), 84-87, 2012
Zorunlu olanlar: Canadian Institutes of Health Research, Cancer Research UK
Long-term worries after colposcopy: which women are at increased risk?
L Sharp, SC Cotton, ME Cruickshank, NM Gray, K Neal, K Rothnie, ...
Women's health issues 25 (5), 517-527, 2015
Zorunlu olanlar: UK Medical Research Council
Yayıncılık ve maddi kaynak bilgileri otomatik olarak bir bilgisayar programı tarafından belirlenmektedir